New light therapy for brain cancer shows promise in early trial
Disease control
Terminated
This trial tested a light-activated drug called PD L 506 (5-aminolevulinic acid) in 17 adults with a type of aggressive brain tumor called glioblastoma that could not be fully removed by surgery. The drug is given by mouth and then activated by a laser inserted into the brain to …
Phase: PHASE2 • Sponsor: photonamic GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC